Emily Singer commissions and edits scientist-written content and develops new resources for the community. She joined The Transmitter in 2023 and has previously held a variety of editorial roles at the Simons Foundation, including editor for neuroscience collaborations, and senior biology writer and contributing editor at Quanta Magazine. Before joining the foundation, she was biomedical editor at Technology Review.
Emily Singer
Chief opinion editor
The Transmitter
From this contributor
How insights from network theory can boost interdisciplinary efforts
By
Emily Singer
23 February 2026 | 0 min watch
Parents turn their skills to furthering autism research
By
Emily Singer
9 May 2013 | 7 min read
Gender differences take center stage at autism conference
By
Emily Singer
4 May 2013 | 6 min read
Education
- Certificate in science communication, University of California, Santa Cruz
- B.A. in biology, University of California, Santa Cruz
Fellowships
- AAAS Mass Media Fellowship
Explore more from The Transmitter
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
By
Lauren Schenkman
4 June 2026 | 5 min read
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
By
Brady Huggett
4 June 2026 | 24 min listen
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read